Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
APGNW was delisted on the 22nd of August, 2023.
11 hedge funds and large institutions have $890K invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
31% less capital invested
Capital invested by funds: $1.29M → $890K (-$404K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$123K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.57K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$7.88K |
| 4 |
Jane Street
New York
|
+$561 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$171K |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$9.59K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$192 |
APGNW Hedge Fund Activity: Q3 2021 in Review
11 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q3 2021, worth a combined $890K — down 31% from $1.29M a quarter earlier.
Fund positioning in APGNW was balanced in Q3 2021: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was K2 Principal Fund, opening a new position worth an estimated $123K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $171K sold.
- 11 institutional investors held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $890K of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q3 2021, down 31% quarter-over-quarter.
- 3 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q3 2021 and 3 closed out, a net change of 0 holders.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant buyer in Q3 2021 was K2 Principal Fund, an estimated $123K added.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant seller in Q3 2021 was Fir Tree Capital Management, an estimated $171K sold.
Based on aggregated 13F filings for Q3 2021.